Practices
Industries
Value-Added Services
Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.
Advancing professional knowledge and offering credits for attorneys, staff and other professionals.
Helping clients respond correctly when a crisis occurs.
Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.
Leveraging law and technology to deliver sound solutions.
Delivering seamless service through partnerships across the globe.
Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.
Industry-leading conferences focused on affordable housing, tax credits, and more.
Providing actionable information to support strategic decision-making.
Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.
Offering a range of investment management and fiduciary services.
Bringing together companies and investors for tomorrow’s new deals.
Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.
Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.
Creating positive impact in our communities through increasing equity, access, and opportunity.
Rich Tilghman, a partner in Nixon Peabody’s Complex Disputes practice, assists clients in resolving complex commercial litigation matters. He represents a broad range of clients in state and federal courts and alternative dispute resolution forums throughout the country, with an emphasis on pharmaceutical, life sciences, and biometric privacy disputes. Rich also co-leads the firm’s Biometric Privacy team.
Many of the disputes I handle involve the development and manufacture of pharmaceutical products. I frequently work with clients in highly regulated industries, including pharmaceuticals, healthcare, and life sciences. I handle commercial disputes with vendors and customers, breach of contract actions, quality-related disputes, royalty disputes, and theft of confidential information and trade secrets. I have represented clients in several high-stakes litigation claims involving third-party service providers to health, welfare, and retirement plans. I also work with companies in the medical and adult-use cannabis sector.
I keep the client’s interests at the forefront by looking for efficient, cost-effective ways to avoid or resolve litigation. When cases cannot be resolved, I act as a forceful advocate to meet my clients’ business and legal objectives.
I have defended numerous clients against claims alleging the misuse of biometric data. I also counsel clients on compliance with biometric privacy rules and regulations. My thought leadership in the biometric privacy arena includes news articles, industry presentations, and publications regarding all facets of biometric privacy litigation and regulation.
I litigate cases and advise clients on matters involving trade secrets, non-disclosure agreements, breach of confidentiality provisions, restrictive covenants, and other confidential business information.
As we have exited the pandemic, the number of pharmaceutical manufacturing sites inspected by the FDA has increased substantially. I am keeping an eye on the ensuing fallout for manufacturers and their customers.
In this article, Chicago Complex Commercial Disputes partner Rich Tilghman discusses the impact of a recent Ninth Circuit ruling recognizing the plaintiffs’ standing in a class action suit accusing Facebook of violating Illinois’ biometric law through its use of facial recognition technology.
Illinois
U.S. District Court, Northern District of Illinois
Federal Trial Bar, Northern District of Illinois
U.S. Court of Appeals, Federal Circuit
Boston College, B.S., cum laude
DePaul University College of Law, J.D., summa cum laude; Managing Editor of Notes and Comments, DePaul Law Review; Order of the Coif
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe